CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Nanobodies are well-established targeting ligands for molecular imaging and therapy. Their short circulation time enables early imaging and reduces systemic radiation exposure. However, shorter circulation time leads to lower tracer accumulation in the target tissue. Cell-penetrating peptides (CPPs)...
Main Authors: | Estel Collado Camps, Sanne A. M. van Lith, Cathelijne Frielink, Jordi Lankhof, Ingrid Dijkgraaf, Martin Gotthardt, Roland Brock |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/7/602 |
Similar Items
-
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01) -
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
by: Jing Zuo, et al.
Published: (2017-10-01) -
Epidermal Delivery of Retinyl Palmitate Loaded Transfersomes: Penetration and Biodistribution Studies
by: Eloy Pena-Rodríguez, et al.
Published: (2020-01-01) -
Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays
by: Qizhong Lu, et al.
Published: (2020-01-01) -
Nanobodies as Versatile Tool for Multiscale Imaging Modalities
by: Marco Erreni, et al.
Published: (2020-12-01)